YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Nixon sues drug companies for Medicaid scam

Posted online
Attorney General Jay Nixon has filed suit against 13 pharmaceutical companies for allegedly reporting inflated Medicaid reimbursement prices and costing taxpayers millions of dollars.

According to Nixon’s lawsuits, the companies sold drugs to Medicaid providers and pharmacies for one price, and then reported a higher price to Medicaid for provider reimbursements. Nixon estimates the scheme cost Missouri taxpayers about $19 million since 1994.

In one instance, a drug used to treat heartburn was sold to a provider for about 7 cents per unit, but the price reported for reimbursement was more than $1.42 per unit.

“By reporting inflated prices that were then used to calculate Medicaid reimbursement, the companies were defrauding taxpayers in order to increase their market shares,” Nixon said in a news release.

The lawsuits are against Mylan Laboratories Inc. and its subsidiary Mylan Pharmaceuticals Inc.; Teva Pharmaceuticals USA Inc., its parent company Teva Pharmaceutical Industries Ltd. and Novopharm, a subsidiary of Teva Pharmaceutical Industries; Watson Pharmaceuticals Inc. and its subsidiary Watson Pharma Inc.; and Boehringer Ingelheim Roxane Inc., its parent company Boerhinger Ingelheim Corp. and four related corporations.

The drugs prescribed included antibiotics and those used to treat anxiety, heartburn and other ailments and diseases.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences